Modern Healthcare - - LATE NEWS -

Beau­mont Health Sys­tem in Royal Oak, Mich., which op­er­ates the state’s largest hospi­tal, is at­tempt­ing an­other merger less than a year af­ter a pre­vi­ous failed deal.

Beau­mont and two other south­east­ern Michi­gan health sys­tems have signed a let­ter of in­tent to cre­ate a $3.8 bil­lion or­ga­ni­za­tion that will bring their eight hos­pi­tals un­der one um­brella. The pro­posal calls for Beau­mont, Bots­ford Health Care in Farm­ing­ton Hills and Oak­wood Health­care in Dear­born to com­bine their bal­ance sheets and op­er­a­tions un­der a sin­gle lead­er­ship struc­ture. The pro­posal comes less than a year af­ter 1,070-bed Beau­mont called off its merger with 10-hospi­tal Henry Ford Health Sys­tem in Detroit.

The Amer­i­can Hospi­tal As­so­ci­a­tion is push­ing the Food and Drug Ad­min­is­tra­tion to be more ag­gres­sive in get­ting man­u­fac­tur­ers of sa­line and other IV flu­ids to in­crease pro­duc­tion to al­le­vi­ate short­ages.

“The cur­rent short­ages of IV fluid are un­ac­cept­able and must be re­solved quickly to pre­vent a neg­a­tive im­pact on pa­tient care,” the AHA wrote in a let­ter to FDA Com­mis­sioner Mar­garet Ham­burg. Hos­pi­tals are man­ag­ing the short­fall by us­ing smaller IV bags, switch­ing pa­tients to ap­pro­pri­ate al­ter­na­tives when pos­si­ble and pri­or­i­tiz­ing pa­tients based on clin­i­cal fac­tors.

The num­ber of an­nual med­i­cal de­vice re­calls nearly dou­bled be­tween fis­cal 2003 and 2012, ac­cord­ing to a re­port Fri­day from the Food and Drug Ad­min­is­tra­tion. The agency at­trib­uted the in­creases to en­hanced in­ter­ac­tion with de­vice man­u­fac­tur­ers and de­vice-safety ini­tia­tives from the FDA’s Cen­ter for De­vices and Ra­di­o­log­i­cal Health. Re­calls as­so­ci­ated with ra­di­ol­ogy de­vices such as lin­ear ac­cel­er­a­tors and CT scans were most fre­quently re­ported, with more than 250 re­calls re­ported in 2012. Car­dio­vas­cu­lar de­vices, like de­fib­ril­la­tors, had the sec­ond-high­est num­ber of re­calls that year, more than 150, the re­port found. Be­tween 2004 and 2012, ap­prox­i­mately 10% of re­calls came from prod­ucts that had re­ceived FDA mar­ket­ing au­tho­riza­tion within the pre­vi­ous year.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.